CellaVision AB: Interim Report January-March 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Strong cash flow and successful product development

January 1-March 31 2014

* Net sales increased by 28 % to SEK 43.2 million (33.8).
* Operating profit increased to SEK 7.5 million (-0.7).
* Profit before tax increased to SEK 7.4 million (-1.5).
* Earnings per share increased to SEK 0.25 (-0.06).
* Two new patents granted for the Asian market.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC